Dr. Neil Schauer is a distinguished leader in the biopharmaceutical and food biotechnology sectors, leveraging over 30 years of experience to drive innovation and excellence in therapeutic biologics and recombinant food products. As the Principal Consultant at Schauer Biologics Consulting, LLC, Dr. Schauer specializes in...
Dr. Neil Schauer is a distinguished leader in the biopharmaceutical and food biotechnology sectors, leveraging over 30 years of experience to drive innovation and excellence in therapeutic biologics and recombinant food products. As the Principal Consultant at Schauer Biologics Consulting, LLC, Dr. Schauer specializes in strategic planning and tactical support for the development and manufacturing of a diverse range of products, including recombinant therapeutic proteins, live biotherapeutics (LBPs), and precision fermentation-based food products. His extensive expertise in protein chemistry and biopharmaceuticals enables him to evaluate and optimize internal manufacturing processes effectively, ensuring compliance with Good Manufacturing Practices (GMP) and validation standards.
Dr. Schauer's role also encompasses the critical evaluation and selection of external Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs), ensuring that his clients partner with the most suitable entities to meet their specific project needs. His deep understanding of the pharmaceutical industry and lifesciences landscape allows him to provide insightful guidance on drug discovery and development, particularly in the realm of recombinant protein purification and process optimization.
Key projects under Dr. Schauer’s leadership have included the successful development of novel recombinant therapeutic proteins that address unmet medical needs, as well as innovative approaches to enhance the nutritional profile of recombinant food products. His commitment to advancing the field through collaboration and knowledge-sharing positions him as a valuable asset to organizations seeking to navigate the complexities of biopharmaceutical development and commercialization. Through his consulting work, Dr. Schauer continues to shape the future of biologics, fostering advancements that benefit both patients and consumers alike.
